Additionally, guanylate-binding protein 5 (GBP5) promotes glioblastoma malignancy through the SRC/ERK1/2/MMP3 pathway [60], implicating ETS1 and MMP3 as downstream effectors of SRC signaling. The gene discussed is ETS1; the disease is glioblastoma.